mrna-4157,pembrolizumab
merck,moderna
['melanoma']
a clinical trial by s dr. jeffrey weber, who presented results today at #aacr23, showed that combining an experimental mrna vaccine with an immunotherapy reduced melanoma recurrence or death by 44% versus immunotherapy alone. for more: 
The latest clinical news and research from experts at @nyulangone. Ranked #2 Best Medical School and #3 Best Hospital in the nation by U.S. News & World Report.